{"pageContent": "Background: In 2012, the United States Preventive Services Task Force (USPSTF) recommended against prostate-specific antigen (PSA) screening, despite evidence that Black men are at a higher risk of prostate cancer-specific mortality (PCSM). We evaluated whether Black men of potentially screening-eligible age (55-69 years) are at a disproportionally high risk of poor outcomes.", "metaData": {"source": "Predicting outcomes in patients with urologic cancers\nhttps://pubmed.ncbi.nlm.nih.gov/18685357/"}}